secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spero Therapeutics, Inc. (SPRO)
CIK:        0001701108
Form:       8-K/A
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001193125-23-256865
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spero Therapeutics corrects 8-K: charter amendment was not approved; files Certificate of Correction
--------------------------------------------------------------------------------

- Amendment No. 1 to 8-K discloses tabulation error in October 5 annual meeting vote.
- Charter amendment proposals (officer exculpation, federal forum clause) did not receive required votes.
- Certificate of Correction filed Oct 16, 2023 to undo previously recorded charter amendment.
- Company states charter remains unchanged as a result of the correction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701108/000119312523256865/0001193125-23-256865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701108/000119312523256865/d563868d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-256865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer